TOR : Target of Rapamycin /

TOR, the Target of Rapamycin was discovered a little over ten years ago in a genetic screen in S. cerevisiae in search of mutants resistant to the cytostatic effects of the anti-mycotic, rapamycin. Since that time orthologues have been identified in all eukaryotes examined to date, including humans....

Full description

Bibliographic Details
Main Author: Thomas, George
Corporate Author: SpringerLink (Online service)
Other Authors: Sabatini, D. M. (David M.), Hall, Michael N.
Format: eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint : Springer, 2004.
Series:Current topics in microbiology and immunology ; 279.
Subjects:
Online Access:Connect to the full text of this electronic book

MARC

LEADER 00000cam a2200000Ma 4500
001 in00003553320
005 20190407123540.0
006 m o d
007 cr nn|||||||||
008 121227s2004 gw a o 000 0 eng d
020 |a 9783642189302 (electronic bk.) 
020 |a 364218930X (electronic bk.) 
035 |a (OCoLC)ocn840291610 
035 |a (OCoLC)840291610 
040 |a I9W  |b eng  |e pn  |c I9W  |d OCLCO  |d OCLCQ  |d UV0  |d OCLCO  |d GW5XE  |d OCLCQ  |d OCLCF  |d UtOrBLW 
049 |a TXAM 
050 4 |a QR46 
082 0 4 |a 616.9041  |2 23 
100 1 |a Thomas, George. 
245 1 0 |a TOR :  |b Target of Rapamycin /  |c edited by George Thomas, David M. Sabatini, Michael N. Hall. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint :  |b Springer,  |c 2004. 
300 |a 1 online resource (x, 364 pages 49 illustrations, 2 illustrations in color.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Current Topics in Microbiology and Immunology, 0070-217X ;  |v 279 
520 |a TOR, the Target of Rapamycin was discovered a little over ten years ago in a genetic screen in S. cerevisiae in search of mutants resistant to the cytostatic effects of the anti-mycotic, rapamycin. Since that time orthologues have been identified in all eukaryotes examined to date, including humans. Recent studies have placed TOR at the interface between nutrient sensing and the regulation of major anabolic and catabolic responses. The significance of understanding the molecular mechanisms which control TOR function has been underscored by Phase 1 clinical trials, showing that rapamycin is not only therapeutically important as an immunosuppressive but is also efficacious in the treatment of solid tumors. Indeed, currently, homologues of rapamycin are in broad-based trials to determine its use in the treatment of other pathological conditions, such as inflammation and restenosis. Given these observations a great deal of attention has been drawn to TOR and its role cellular homoeostasis and human disease. Here we have gathered the leading figures in the field to summarize their own contributions to uncovering TOR function and to speculate where they think the field will be moving in the next few years. 
500 |a Electronic resource. 
650 0 |a Medicine. 
650 0 |a Microbiology. 
650 7 |a Medicine.  |2 fast  |0 (OCoLC)fst01014893 
650 7 |a Microbiology.  |2 fast  |0 (OCoLC)fst01019576 
655 7 |a Electronic books.  |2 local 
700 1 |a Sabatini, D. M.  |q (David M.) 
700 1 |a Hall, Michael N. 
710 2 |a SpringerLink (Online service) 
830 0 |a Current topics in microbiology and immunology ;  |v 279. 
856 4 0 |u http://proxy.library.tamu.edu/login?url=http://link.springer.com/10.1007/978-3-642-18930-2  |z Connect to the full text of this electronic book  |t 0 
994 |a 92  |b TXA 
999 |a MARS 
999 f f |s 827a6cbb-d931-38b5-b6f3-a52cab2a629a  |i 0d6da618-729f-3d61-b42c-5a6aee50264d  |t 0 
952 f f |a Texas A&M University  |b College Station  |c Electronic Resources  |d Available Online  |t 0  |e QR46  |h Library of Congress classification 
998 f f |a QR46  |t 0  |l Available Online